Napredna pretraga

Pregled bibliografske jedinice broj: 530915

Intragastric balloon treatment for obesity: results of a large single center prospective study


Štimac, Davor; Klobučar-Majanović, Sanja; Turk, Tamara; Kezele, Borivoj; Licul, Vanja; Crnčević-Orlić, Željka
Intragastric balloon treatment for obesity: results of a large single center prospective study // Obesity surgery, 21 (2011), 5; 551-555 doi:10.1007/s11695-010-0310-0 (međunarodna recenzija, članak, znanstveni)


Naslov
Intragastric balloon treatment for obesity: results of a large single center prospective study

Autori
Štimac, Davor ; Klobučar-Majanović, Sanja ; Turk, Tamara ; Kezele, Borivoj ; Licul, Vanja ; Crnčević-Orlić, Željka

Izvornik
Obesity surgery (0960-8923) 21 (2011), 5; 551-555

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Bioenteric intragastric balloon – BIB – Obesity – Weight loss – Fatty liver – Cardiovascular risk

Sažetak
The intragastric balloon is a widely used method in the treatment of obesity indicated for those patients who have failed to achieve and maintain the weight loss with conventional measures or for preparation of patients who are candidates for bariatric surgery. From April 2007 to April 2009, 171 consecutive patients (111 females, 60 males ; mean age 39.2 ± 10.5, mean weight 123.2 ± 27.1 kg) were evaluated before and 6 months after bioenteric intragastric balloon (BIB) placement by assessment of anthropometric and biochemical parameters. The mean BMI during balloon treatment declined from 41.9 ± 7.3 to 36.0 ± 7.9 kg/m² (p < 0.001) with a percentage of excess weight loss of 39.7 ± 23.6 and percentage of excess body mass index loss of 39.5 ± 25.1. A significant improvement in blood pressure, glycemia, and triglyceride level but not in total cholesterol, high-density lipoprotein, and low-density lipoprotein cholesterol levels was seen. Results of this large prospective single center study confirmed that intragastric balloon is useful and safe method for promoting weight loss. Due to improvement of metabolic parameters, treatment with BIB results in reduction of cardiovascular risk and provides a sustained benefit on liver function in obese patients.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekt / tema
062-0620226-0208 - Kost kao ciljni organ u šećernoj bolesti i upalnim bolestima crijeva (Željka Crnčević Orlić, )

Ustanove
Medicinski fakultet, Rijeka,
Klinički bolnički centar Rijeka

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati